|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 149.50 GBX | 0.00% |
|
+4.18% | +16.80% |
| 29/07 | Diaceutics PLC Reports Revenue Results for the Half Year Ended 30 June 2026 | CI |
| 03/06 | Diaceutics PLC, 2025 Earnings Call, May 26, 2026 |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 3.08x | - | 2.54x | 11.59x | 37.13x | -.--% | 170M | |
| -88.87x | 8.08x | 0.25x | 18.94x | 47.93x | -70.63x | -.--% | 48.62B | |
| 31.74x | 3.36x | 0.45x | 2.36x | 20.36x | 34.53x | 1.5% | 3.46B | |
| 92.71x | 6.3x | 1.2x | 12.42x | 19.37x | 115.01x | 0.28% | 3.32B | |
| 36x | 13.06x | 2.23x | 11.69x | 25.17x | 29.19x | 1.79% | 2.08B | |
| -89.11x | 4.46x | 1.05x | - | - | - | 0.08% | 1.52B | |
| 31.68x | 2.58x | 3.61x | 4.2x | 16.85x | 21.91x | 0.57% | 1.47B | |
| 40.09x | 8.14x | 1.24x | 16.57x | 25.71x | 28.21x | 0.58% | 1.19B | |
| 14.77x | 4.36x | 0.37x | - | - | - | 0.39% | 1.1B | |
| -1.69x | - | 0.21x | 5.04x | 8.24x | 95.21x | -.--% | 458M | |
| 24.52x | 3.1x | 1.45x | 2.62x | 8.28x | 13.78x | - | 160M | |
| -45.83x | 4.77x | 0.53x | 1.58x | 11.49x | -46.97x | - | 130M | |
| Average | 4.18x | 5.57x | 1.15x | 7.80x | 19.50x | 25.74x | 0.52% | 5.31B | |
| Weighted average by Cap. | -60.70x | 7.58x | 0.50x | 16.77x | 42.27x | -45.19x | 0.19% |
- Stock Market
- Stocks
- DXRX Stock
- Sector Diaceutics PLC
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
